Florida Cancer Specialists & Research Institute, LLC held a ribbon-cutting ceremony on June 16, 2022 to celebrate the opening of a new clinical site in Kissimmee, FL.
Fort Myers, Fla., June 21, 2022 – Florida Cancer Specialists & Research Institute, LLC (FCS) held a ribbon-cutting ceremony on June 16, 2022 to celebrate the opening of a new clinical site in Kissimmee, FL. Located at 801 W. Oak Street, Kissimmee, FL 34741, the 3,400 square foot office offers a broad range of treatments and services for patients with cancer and blood disorders, including medical oncology/hematology, infusions and an in-house laboratory.
FCS Chief Executive Officer Nathan H. Walcker said, “The opening of our Kissimmee clinic is a significant milestone for FCS and an important step forward in fulfilling our mission. This new location further expands our presence in the heart of central Florida where patients in Osceola County can now benefit from easy access to world-class cancer care close to home.”
“We are extremely excited about this latest expansion to our statewide community oncology network,” said FCS President and Managing Physician Michael Diaz, MD. “Our cancer care experts provide the most advanced treatments and therapies personalized for each patient’s unique needs. Additionally, patients can also participate in promising new treatments through clinical trial opportunities available at our FCS Drug Development Units in nearby Lake Nona and Lake Mary.”
FCS cares for all forms of cancer and blood disorders at nearly 100 locations throughout Florida. The comprehensive team of more than 250 physicians, 220 advanced practice providers and nearly 4,000 team members share a commitment to providing patients and their families with the care and support they need at every step of their cancer journey.
FCS Board-certified medical oncologists Geetha Akula, MD, Martin Dietrich, MD, PhD, Aamer Farooq, MD and Michel Velez, MD provide care to patients at the new FCS Kissimmee location.
Members and health care teams from the community attended the ribbon cutting, including Robin Hughes of Osceola Chamber of Commerce who noted, “We are so pleased to welcome Florida Cancer Specialists & Research Institute to our community. Having such high-quality cancer care in our immediate backyard will be highly beneficial for Osceola County.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Michelle Robey, Vice President of Marketing
Michelle.Robey@FLCancer.com
(813) 767-9398
Jen Bradley, Director of Corporate Communications
Jennifer.Bradley@FLCancer.com
(847) 280.1740
Petosemtamab and Pembrolizumab: A Promising Pair in HNSCC Treatment
July 2nd 2024In an interview, Cesar Augusto Perez, MD, delved into the findings from a phase 2 study evaluating petosemtamab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Read More